Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
PainChek Ltd ( (AU:PCK) ) has provided an announcement.
PainChek Ltd announced an upcoming investor webinar to discuss its quarterly update and financials. The company continues to expand its influence in pain assessment technology, with significant usage in aged care facilities globally and ongoing efforts to enter the home care market. This strategic move may enhance PainChek’s market position and offer more comprehensive services to stakeholders.
More about PainChek Ltd
PainChek Ltd is a company operating in the healthcare industry, specializing in developing smartphone-based pain assessment and monitoring applications. Their primary product, the PainChek app, is a regulatory-cleared medical device designed to assess pain in individuals who may have difficulty self-reporting, using AI technology to automate the process. The app is widely used in aged care facilities across several countries, including Australia, Canada, and the UK, and is expanding its application to home care services.
YTD Price Performance: -10.0%
Average Trading Volume: 795,961
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$48.81M
Find detailed analytics on PCK stock on TipRanks’ Stock Analysis page.
